Encore Medical to start roadshow Thursday for $165 million eight-year notes

By Paul A. Harris

St. Louis, Sept. 15 - Encore Medical Inc. will start a roadshow Thursday for a $165 million offering of eight-year senior subordinated notes, according to an informed source.

Pricing is expected to take place early in the Sept. 27 week

Banc of America Securities will run the books for the Rule 144A offering. Albany Capital will be the co-manager.

The notes will come with four years of call protection.

Proceeds will be used to fund Encore's $360 million acquisition of St. Paul, Minn.-based Empi Inc., a medical device company focused on products used for pain management, orthopedic rehabilitation and physical therapy.

Austin, Texas-based Encore Medical is a diversified orthopedic device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.